Eisai Company Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Eisai Company Limited with three other
companies in this sector in the United States:
Regeneron Pharmaceuticals Incorporated
sales of $4.86 billion
of which 100%
was Research & Development),
Endo International PLC
of which 64%
was Generics), and
of which 50%
Eisai Company Limited reported sales of $4.56 billion
March of 2016.
decrease of 8.2%
versus 2015, when the company's sales were $4.97 billion.